missing translation for 'onlineSavingsMsg'
Learn More

TRAILR2/TNFRSF10B Antibody (B-K29), Alexa Fluor™ 647, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-14595AF647

Product Code. 18580137

  • € 493.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

TRAILR2/TNFRSF10B Monoclonal antibody specifically detects TRAILR2/TNFRSF10B in Human samples. It is validated for Flow Cytometry, ELISA
TRUSTED_SUSTAINABILITY
Specifications

Specifications

TRAILR2/TNFRSF10B
Monoclonal
Alexa Fluor 647
CD262, CD262 antigen, death domain containing receptor for TRAIL/Apo-2L, Death receptor 5, DR5TRICK2B, Fas-like protein, KILLER/DR5, KILLERapoptosis inducing protein TRICK2A/2B, TNF-related apoptosis-inducing ligand receptor 2, TRAIL receptor 2, TRAIL-R2apoptosis inducing receptor TRAIL-R2, TRAILR2cytotoxic TRAIL receptor-2, TRICK2, TRICK2A, TRICKB, tumor necrosis factor receptor superfamily member 10B, tumor necrosis factor receptor superfamily, member 10b, tumor necrosis factor receptor-like protein ZTNFR9, ZTNFR9
Recombinant human TRAILR2/TNFRSF10B
0.1 mL
Apoptosis, Biologically Active Proteins, Cancer, Death Receptor Signaling Pathway
8795
Store at 4°C in the dark.
IgG1 κ
Flow Cytometry, ELISA
B-K29
50mM Sodium Borate
Mouse
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.